Mihaela Radu
About Mihaela Radu
Mihaela Radu is the Country Controller at AstraZeneca Pharma SRL in Bucharest, Romania, with over 25 years of experience in finance and accounting roles across various industries.
Title and Current Role
Mihaela Radu currently holds the position of Country Controller at AstraZeneca Pharma SRL, based in Bucharest, Bucuresti, Romania. In this role, she oversees financial operations, ensuring compliance with local and international financial regulations.
Professional Experience
Mihaela Radu has over 25 years of experience in finance and accounting roles. She began her career in 1997 as an economist at INMA Bucuresti. She then moved to Upetrom 1 Mai Ploiesti, another economist role, before transitioning into accounting positions. Over the years, she has served as Chief Accountant at several prominent companies including Glass Art SRL, Swedwood, Bayer, Bunge, and Actavis. Additionally, she has held roles such as Chief Accountant and Country Controller at Bristol-Myers Squibb before her long tenure at AstraZeneca Pharma SRL.
Experience in the Pharmaceutical Industry
Mihaela Radu has considerable experience in the pharmaceutical sector. She worked at Actavis as Chief Accountant from 2010 to 2015. This experience was further built upon at AstraZeneca Pharma SRL, where she has been serving as a Finance Controller since 2015. Her extensive experience in this industry includes handling complex financial operations and ensuring regulatory compliance.
Education and Qualifications
Mihaela Radu studied at Academia de Studii Economice din București, where she earned her bachelor's degree in economics, graduating in 1997. Her educational background laid the foundation for her extensive career in finance and accounting.
Work in Multinational Companies
Throughout her career, Mihaela Radu has gained significant experience working in multinational corporations. Her roles at Bayer and Bristol-Myers Squibb have equipped her with a deep understanding of global finance operations, which she has successfully implemented in her current role at AstraZeneca Pharma SRL.